DIFFERENTIAL ACTIVATION REQUIREMENTS OF CLONED T CELLS
克隆 T 细胞的差异激活要求
基本信息
- 批准号:3137646
- 负责人:
- 金额:$ 9.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-09-01 至 1989-08-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte T lymphocyte antibody formation antigens cell cell interaction cell population study clone cells density gradient ultracentrifugation flow cytometry helper T lymphocyte histocompatibility antigens hybridomas immunochemistry immunotherapy interleukin 2 leukocyte activation /transformation macrophage macrophage activating factor radiotracer suppressor T lymphocyte
项目摘要
The goal is to gain further insight into mechanisms governing T cell
activation and its regulation. To this end, a large panel of L3T4+ inducer
T cell clones has been generated. These clones display distinct
differences in their requirements for activation. For example, some clones
respond to antigen presented either by macrophages or B cells, while others
respond to antigen presented by macrophages but not by B cells. Some
clones respond to determinants present on B cells but not macrophages.
Several of the nominal antigen specific T cell clones are also reactive
against allogeneic MHC and Mls determinants.
Using these clones I propose to:
1) examine T cell clones which fail to proliferate in response to antigen
presented by B cells in order to determine a) how their activation
requirements differ from those of T cell clones which do respond to antigen
presented by B cells and b) how these two types of clones differ in their
ability to induce antibody synthesis;
2) examine in detail the activation of T cell clones by Mls determinants
and attempt to characterize these determinants;
3) examine mechanisms regulating the activation of NP-specific inducer T
cells by analyzing their inhibition by NP-specific suppressor factors
derived from NP-specific suppressor T cell hybridomas.
This proposal will attempt to increase our understanding of the molecular
and cellular interactions governing T cell activation and its suppression.
Such an understanding is vital to the favorable manipulation of the immune
system in many disease states.
目标是进一步了解控制T细胞的机制
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rosemarie H DeKruyff其他文献
Rosemarie H DeKruyff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rosemarie H DeKruyff', 18)}}的其他基金
TIM recognition of PtdSer on apoptotic cells and the regulation of immunity
TIM对凋亡细胞PtdSer的识别及免疫调节
- 批准号:
8495892 - 财政年份:2010
- 资助金额:
$ 9.07万 - 项目类别:
TIM recognition of PtdSer on apoptotic cells and the regulation of immunity
TIM对凋亡细胞PtdSer的识别及免疫调节
- 批准号:
8704253 - 财政年份:2010
- 资助金额:
$ 9.07万 - 项目类别:
TIM recognition of PtdSer on apoptotic cells and the regulation of immunity
TIM对凋亡细胞PtdSer的识别及免疫调节
- 批准号:
8082683 - 财政年份:2010
- 资助金额:
$ 9.07万 - 项目类别:
TIM recognition of PtdSer on apoptotic cells and the regulation of immunity
TIM对凋亡细胞PtdSer的识别及免疫调节
- 批准号:
7949426 - 财政年份:2010
- 资助金额:
$ 9.07万 - 项目类别:
TIM recognition of PtdSer on apoptotic cells and the regulation of immunity
TIM对凋亡细胞PtdSer的识别及免疫调节
- 批准号:
8288920 - 财政年份:2010
- 资助金额:
$ 9.07万 - 项目类别:
TIM-1, TIM-3 and TIM-4: A gene family that regulates tolerance and immunity
TIM-1、TIM-3 和 TIM-4:调节耐受性和免疫性的基因家族
- 批准号:
8306826 - 财政年份:2003
- 资助金额:
$ 9.07万 - 项目类别:
TIM-1, TIM-3 and TIM-4: A gene family that regulates tolerance and immunity
TIM-1、TIM-3 和 TIM-4:调节耐受性和免疫性的基因家族
- 批准号:
7995554 - 财政年份:2003
- 资助金额:
$ 9.07万 - 项目类别:
TIM-1, TIM-3 and TIM-4: A gene family that regulates tolerance and immunity
TIM-1、TIM-3 和 TIM-4:调节耐受性和免疫性的基因家族
- 批准号:
8380754 - 财政年份:2003
- 资助金额:
$ 9.07万 - 项目类别:
TIM-1, TIM-3 and TIM-4: A gene family that regulates tolerance and immunity
TIM-1、TIM-3 和 TIM-4:调节耐受性和免疫性的基因家族
- 批准号:
8831793 - 财政年份:2003
- 资助金额:
$ 9.07万 - 项目类别:
TIM-1, TIM-3 and TIM-4: A gene family that regulates tolerance and immunity
TIM-1、TIM-3 和 TIM-4:调节耐受性和免疫性的基因家族
- 批准号:
8507123 - 财政年份:2003
- 资助金额:
$ 9.07万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 9.07万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 9.07万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 9.07万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 9.07万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 9.07万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 9.07万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 9.07万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 9.07万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 9.07万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 9.07万 - 项目类别:
Discovery Grants Program - Individual